Global tuberculosis deaths fell to 1.13 million in 2025 down from 1.18 million the previous year, though the rate of decline misses major international targets, ONU Info reported.
More than 10 million people contracted the preventable infectious disease, keeping it the leading cause of mortality from a single infectious agent ahead of HIV and AIDS.
The annual report from the World Health Organization shows deaths have dropped 35 percent since 2015, but that milestone arrives five years late after missing a 2020 target date. A projected 75 percent reduction for 2025 remains out of reach, while the incidence rate fell only 14 percent over the decade compared to a hoped-for 50 percent drop.
“La baisse continue des cas et des décès est très encourageante, surtout compte tenu des difficultés auxquelles de nombreux pays ont été confrontés en raison des réductions de financement,” said Tedros Ghebreyesus, directeur général of the OMS, in a press statement reported by ONU Info.
Ghebreyesus also said that over a million people still die annually from a condition that can be prevented and cured.
- Tuberculosis is caused by bacteria that usually attack the lungs, spreading through the air when an infected person coughs or sneezes.
The epidemic concentrates heavily in impoverished nations, with thirty countries accounting for 88 percent of all new infections. India represents roughly a quarter of the global total, followed by Indonesia, the Philippines, China, Pakistan, and the Democratic Republic of the Congo.
Regional disparities remain stark across the globe. Incidence rates dropped 42 percent in Europe and 30 percent in Africa since 2015, but shrank just 6.6 percent in the Eastern Mediterranean. Across the Americas, rates increased for the fifth year to exceed 2015 levels.
Screening obstacles leave millions outside official statistics. Out of 10.6 million people who fell ill, authorities diagnosed and declared only 8.4 million, leaving 2.2 million cases uncounted.
| Indicator | 2025 Statistics | Previous Metrics / Targets |
|---|---|---|
| Global Deaths | 1.13 million | 1.18 million (prior year) |
| New Infections | Over 10 million | Nearly unchanged year-over-year |
| Diagnosed Cases | 8.4 million | 10.6 million total estimated cases |
| Resistant Treatment Access | 42 percent | Estimated 370,000 resistant patients |
International funding dedicated to fighting the disease fell 14 percent in 2025 to $940 million. National governments stepped in by increasing domestic spending by 14 percent to reach $5.6 billion, according to data cited by ONU Info.
Total low- and middle-income country mobilization reached $6.6 billion, falling far short of the $22 billion annual requirement set for 2027. Research efforts also face chronic underfunding, receiving just $1.2 billion in 2023, which is under a quarter of the annual target.
Economic burdens extend directly to affected households, where nearly half of families face costs exceeding 20 percent of their annual income. Poverty, malnutrition, and limited care access continue to sustain transmission vectors worldwide.
Effective treatments have prevented an estimated 86 million deaths since 2000 through coordinated public health interventions. Without accelerated diagnostic rollout and increased financial commitments, the goal of ending the epidemic by 2030 remains distant.
- ONU Info.
- WHO News Release.
